New VUMC F&A Rate for Commercial/Industry Research Contract Activity

Please note that, starting August 1, 2019, VUMC has a new indirect cost rate (also known as a facilities and administrative [F&A] rate) for commercial/industry research contract activity: Clinical trials for drugs, vaccines, devices, and all other forms of clinical trial investigation sponsored by industry: Previous Rate: 29% of Total Direct Costs New Rate: 35% of Total Direct Costs Other industry-sponsored research projects that are conducted in academic/medical center space: Previous Rate: 60% of Total Direct Costs New Rate: 70% of Total Direct Costs Implementation is as follows: All new agreements should utilize these rates, effective August 1, 2019. Users should utilize a Total Direct Cost (TDC) methodology when applying these rates. Any contracts currently in negotiation and pending final signatures (i.e., budget has been finalized with the industry partner) and all active commercial/industry contractual agreements budgeted at previous rates are grandfathered in at the originally agreed-upon rates (29%/60%). Recovery of indirect costs is necessary to support institutional infrastructure and

read more New VUMC F&A Rate for Commercial/Industry Research Contract Activity